Stock Watch: Pharma Financial Forecasts Cannot Withstand Headwinds Forever

Q2 Earnings Season Follows Heavy Tariff, Currency, Medicare/Medicaid Pressures

 
• By Andy Smith
  
Stock Watch Image, Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Stock Watch

More from Scrip